Digital Health Investments Top $2.6B* in the First Six Months of 2014

by Fenwick & West Life Sciences Group
Contact

Thanks to an impressive showing in April, digital health investment in the first half of 2014 totaled $2.676 billion. There were a total of 38 deals for $20 million or more from January through June, with more than two-thirds of the $20 million-plus investments occurring in Q2.

Three of the top ten investments in June went to therapeutic focused companies, including the biggest round of the month, a $120 million Series G round for Proteus Digital Health. As we noted in an earlier post, Proteus closed one of the largest digital health investments in 2013 with a $45 million Series F round. The company has an FDA-approved ingestible sensor product and is building out additional products based on that same core technology. Investors in the latest round were not disclosed.

The second largest round of the month went to Zenefits, an online platform for benefits, payroll and other HR services. The company closed a $66.5 million Series B financing that included SV Angel, Horowitz and Institutional Venture Partners.

Grand Rounds received the third largest investment in June in a Series B round led by Venrock, Greylock Partners and Harrison Metal. The cloud-based software company provides an outcomes management platform that employers can make available to their employees.

As Tech Crunch recently noted, women’s health apps have drawn a lot of investor interest. There are two women’s mHealth companies among the top ten investments in June. Meets You is a mobile health tracking application and social media platform for women, which is based in Xiamen, China. Matrix Partners China, SIG Asia Investments and K2 Ventures participated in the $35 million Series C round.

Ranking fifth among June investments was Chrono Therapeutics, a drug delivery company. Its wearable drug delivery technology allows for tailored timing and dosage of drugs. Chrono received a Series A investment totaling $32 million. Investors included Canaan Partners, Fountain Healthcare Partners, 5AM Ventures, Mayo Clinic and GE Ventures.

The sixth largest investment of the month went to another women’s mobile health tracking company from China. The Beijing company, Kang Zhi Le Si Network, took in $30 million in a Series C round from Ceyuan Ventures, Sequoia Capital China and Bertelsmann Asia Investments. This investment comes on the heels of a $20 million round that the company received in May.

NantHealth, a cloud-based clinical operating software provider that received a $100 million investment in May from a sovereign wealth fund, received a corporate minority investment in June for $25 million from Celgene.

The next largest investment was a $24.2 million venture debt investment from Hercules Technology Growth Capital. The financing went to CareCloud, a cloud-based EMR and practice management software provider headquartered in Florida.

Definiens provides image analysis and data mining solutions for life sciences companies. The Big Data company based in Munich, Germany received a $20.4 million Series C investment that included Cipio Partners, Wellington Partners, TVM Capital and Glide Healthcare Partners.

Rounding out the top ten for June is Senseonics, a Maryland-based company that is developing a fully-implantable glucose monitoring system. New Enterprise Associates, HealthCare Ventures, Delphi Ventures, Anthem Capital and Greenspring Associates participated in the $20 million Series E round.

*Note: This aggregate dollar investment amount includes private equity financings only. It excludes public offerings, debt offerings/facilities and convertible debt transactions.

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Fenwick & West Life Sciences Group | Attorney Advertising

Written by:

Fenwick & West Life Sciences Group
Contact
more
less

Fenwick & West Life Sciences Group on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.